Zhang et al. (2021) reported that the combination of ECA and afatinib had a significant impact on the expression of Wnt1/β-catenin and Wnt5A mRNA in H1975 lung cancer cells, although no significant difference was observed in A549 lung cancer cells [38]. This evidence concerns the gene WNT5A and lung carcinoma.